A detailed history of Polymer Capital Management (Hk) LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Polymer Capital Management (Hk) LTD holds 5,000 shares of CRL stock, worth $933,250. This represents 0.23% of its overall portfolio holdings.

Number of Shares
5,000
Previous 3,751 33.3%
Holding current value
$933,250
Previous $775 Million 27.1%
% of portfolio
0.23%
Previous 0.16%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$187.96 - $245.29 $234,762 - $306,367
1,249 Added 33.3%
5,000 $985 Million
Q2 2024

Aug 13, 2024

BUY
$206.39 - $268.73 $51,803 - $67,451
251 Added 7.17%
3,751 $775 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $575,820 - $835,940
3,500 New
3,500 $827 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Polymer Capital Management (Hk) LTD Portfolio

Follow Polymer Capital Management (Hk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polymer Capital Management (Hk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Polymer Capital Management (Hk) LTD with notifications on news.